Keefe Bruyette raised the firm’s price target on The Hanover (THG) to $211 from $208 and keeps an Outperform rating on the shares. The firm upped estimates post the Q1 report to reflect faster net interest income growth, a lower 2026 core loss ratio, and bigger reserve releases. The Hanover’s current valuation underappreciates the company’s profitable growth prospects, the analyst tells investors in a research note.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on THG:
- The Hanover price target raised to $195 from $190 at Morgan Stanley
- The Hanover price target raised to $212 from $204 at Piper Sandler
- Hanover Insurance Delivers Record Q1 in Disciplined Push
- The Hanover price target raised to $205 from $200 at Citizens
- The Hanover reports Q1 operating EPS $5.25, consensus $4.22